We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+28.05%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$10.3B
AUM Growth
+$5.25B
Cap. Flow
+$4.62B
Cap. Flow %
45%
Top 10 Hldgs %
41.75%
Holding
2,600
New
918
Increased
493
Reduced
472
Closed
701

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$353M
2
MSFT icon
Microsoft
MSFT
+$352M
3
AAPL icon
Apple
AAPL
+$256M
4
BABA icon
Alibaba
BABA
+$189M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$125M

Sector Composition

Rank Sector Weight
1 Technology 14.28%
2 Consumer Discretionary 10.77%
3 Healthcare 5.09%
4 Industrials 4.03%
5 Financials 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OUT icon
2276
Outfront Media
OUT
$5.25B
-57,622
Closed -$825K
OVID icon
2277
Ovid Therapeutics
OVID
$547M
-14,561
Closed -$84K
OXY icon
2278
Occidental Petroleum
OXY
$61.3B
-54,450
Closed -$545K
OXY.WS icon
2279
Occidental Petroleum Corp Warrants
OXY.WS
$37.1B
-200,122
Closed -$600K
PAGP icon
2280
Plains GP Holdings
PAGP
$5.31B
-98,332
Closed -$599K
PAHC icon
2281
CALL
Phibro Animal Health
PAHC
$1.47B
-3,300
Closed -$57K
PAHC icon
2282
Phibro Animal Health
PAHC
$1.47B
-47,419
Closed -$825K
PB icon
2283
Prosperity Bancshares
PB
$8.75B
-47,439
Closed -$2.46M
PBR icon
2284
Petrobras
PBR
$123B
-125,530
Closed -$894K
PCRX icon
2285
Pacira BioSciences
PCRX
$983M
-12,173
Closed -$732K
PEB icon
2286
Pebblebrook Hotel Trust
PEB
$2.09B
-100,385
Closed -$1.26M
PEGA icon
2287
Pegasystems
PEGA
$5.52B
-39,250
Closed -$2.38M
PFE icon
2288
CALL
Pfizer
PFE
$160B
-263,500
Closed -$9.2M
PFGC icon
2289
Performance Food Group
PFGC
$16.5B
-21,351
Closed -$739K
PFS icon
2290
Provident Financial Services
PFS
$3.09B
-16,367
Closed -$200K
PHG icon
2291
Philips
PHG
$26.8B
-6,553
Closed -$251K
PHI icon
2292
PLDT
PHI
$4.19B
-9,981
Closed -$270K
PK icon
2293
Park Hotels & Resorts
PK
$3.18B
-64,033
Closed -$640K
PKE icon
2294
Park Aerospace
PKE
$737M
-13,864
Closed -$151K
PKG icon
2295
Packaging Corp of America
PKG
$22.5B
-4,298
Closed -$469K
PLCE icon
2296
Children's Place
PLCE
$55.4M
-12,152
Closed -$345K
PLOW icon
2297
Douglas Dynamics
PLOW
$973M
-9,675
Closed -$331K
PMT
2298
PennyMac Mortgage Investment
PMT
$815M
-50,219
Closed -$807K
PNC icon
2299
PNC Financial Services
PNC
$97B
-7,346
Closed -$807K
PNFP icon
2300
Pinnacle Financial Partners Inc
PNFP
$15.5B
-21,863
Closed -$778K

Similar funds

Michael Gelband's Q4 2020 Portfolio in Review

As of Q4 2020, Michael Gelband held 2,600 positions worth $10.3B, up 105% from $5.02B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Michael Gelband deployed $4.62B of net new capital in Q4 2020, opening 918 new positions and adding to 493 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Charles Schwab, an estimated $82M trimmed.

  • Michael Gelband's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
  • Michael Gelband added most to Amazon in Q4 2020, an estimated $353M increase.
  • Michael Gelband's biggest Q4 2020 reduction was Charles Schwab, cutting an estimated $82M.
  • Michael Gelband fully exited Eli Lilly in Q4 2020, selling an estimated $21.7M.
  • Michael Gelband's ten largest holdings make up 42% of its $10.3B portfolio in Q4 2020.
  • Michael Gelband opened 918 new positions and closed 701 in Q4 2020.
  • Michael Gelband's portfolio value rose 105% quarter-over-quarter to $10.3B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.